23:25 May 25, 2013  

Sanofi India Ltd

HSL Code: HOEMAR   |   BSE Code: 500674  |   NSE Symbol: SANOFI  |   ISIN: INE058A01010
2,470.00
-34.70(-1.39%)
24 May 2013 | 15:55
Prev Close (Rs.)
2,504.70
Open (Rs.)
2,500.00
High (Rs.)
2,524.80
Low (Rs.)
2,452.50
Volume
128
Week Avg. Volume
808
52Wk High - Low Range
2002.10
2899
 
 
04-30-2013
Quarterly Results
02-25-2013
Final Dividend
10-31-2012
Quarterly Results
07-25-2012
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 25, 2012, for :- 1. Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2012; and 2. Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2012.
05-03-2012
Quarterly Results
02-23-2012
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 23, 2012, for approving the audited Accounts for the year ended December 31, 2011 and also to consider recommendation of final Dividend for the said financial year.
11-14-2011
Quarterly Results
07-28-2011
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 28, 2011, for:- 1. Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2011; and 2. Considering the question of declaring an Interim Dividend for the current Financial year ending on December 31, 2011.
04-26-2011
Quarterly Results
02-16-2011
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 16, 2011, for approving the audited Accounts for the year ended December 31, 2010 and also to consider recommendation of final Dividend for the said financial year.
10-25-2010
Quarterly Results
04-27-2010
Quarterly Results
02-24-2010
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 24, 2010, for approving the audited Accounts for the year ended December 31, 2009 and also to consider recommendation of Final Dividend for the said financial year.
10-27-2009
Quarterly Results
07-22-2009
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on July 22, 2009, inter alia, to transact the following: 1. Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2009; and 2. Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2009.
04-28-2009
Quarterly Results
02-17-2009
Aventis Pharma Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on February 17, 2009, for approving the audited Accounts for the year ended December 31, 2008 and also to consider recommendation of Final Dividend for the said financial year.
 
Fetching Data...